Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial Measurement of Pancreatic Stone Protein (PSP) for the Early Recognition and Diagnosis of Sepsis in Intensive Care Unit (ICU) Patients in China: A Multicenter, Prospective, Biomarker-result-blinded Observational Study

NCT07232784 is registered in ClinicalTrials.gov with Fapon Biotech Inc. as lead sponsor.

NCT NCT07232784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07232784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial Measurement of Pancreatic Stone Protein (PSP) for the Early Recognition and Diagnosis of Sepsis in Intensive Care Unit (ICU) Patients in China: A Multicenter, Prospective, Biomarker-result-blinded Observational Study
Lead sponsor
Fapon Biotech Inc.
Phase
Observational
Overall status
Completed
Start date
July 10, 2024
Completion date
March 31, 2025
Enrollment
250 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients at high risk of sepsis